CHIME BioTherapeutics, Inc.

CHIME BioTherapeutics, Inc.

Harnessing Childhood Immune Memory to Fight Cancer

CHIME BioTherapeutics, Inc. is an immuno-oncology company focused on the development of innovative cancer immunotherapies based on the breakthrough concept of recalling and harnessing pre-existing memory immunity from childhood vaccines to treat a variety of cancers.  CHIME BTx is the first corporate spin-off from La Jolla Institute for Allergy and Immunology (LJI, San Diego).  CHIME has obtained an exclusive license to specific intellectual property from LJI.

Area of focus: 
Immunology
Graduation date: 
01/26/2018
Commencement date: 
05/01/2017

Contact

  • Alain Rolland

    CEO & President
    Quote or favorite saying: 
    "If I have seen further, it is by standing on the shoulders of giants." Sir Isaac Newton

Share